Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...
The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...
An advanced practice provider (APP)-led peer review quality assurance (QA) committee was found to be feasible and identified ...
Integrative oncology is a patient-centered approach to cancer care that looks at the whole patient and combines their ...
Among lymphoma survivors experiencing chronic fatigue, a multidisciplinary intervention program has been found to have a ...
While at 3 months fewer patients in supervised physical activity arm reported visual analog scale loss of energy (45% vs 62%) ...
Opening discussions about priorities and learning about inclusive language are among the most impactful steps an advanced ...
A patient with breast cancer was able to avoid unnecessary mastectomy through the use of a virtual reality simulation, ...
Insurance navigation remains a complex but essential skill for oncology advanced practice providers (APPs). According to ...
La-Urshalar Brock, FNP-BC, CNM, describes tactics for managing dermatologic AEs in patients with breast cancer as part of a ...
Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment ...
Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal tumors (GIST), with complete response (CR) or complete resection yielding a twofold increase in median survival, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback